Wolverine Trading’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-21,081
| Closed | -$780K | – | 1494 |
|
2025
Q1 | $780K | Sell |
21,081
-28,466
| -57% | -$1.05M | ﹤0.01% | 488 |
|
2024
Q4 | $1.91M | Buy |
49,547
+33,647
| +212% | +$1.3M | ﹤0.01% | 363 |
|
2024
Q3 | $752K | Sell |
15,900
-1,579
| -9% | -$74.7K | ﹤0.01% | 511 |
|
2024
Q2 | $944K | Sell |
17,479
-12,008
| -41% | -$649K | ﹤0.01% | 420 |
|
2024
Q1 | $2.01M | Buy |
29,487
+9,564
| +48% | +$652K | ﹤0.01% | 242 |
|
2023
Q4 | $1.25M | Buy |
19,923
+863
| +5% | +$54K | ﹤0.01% | 373 |
|
2023
Q3 | $865K | Buy |
19,060
+5,059
| +36% | +$230K | ﹤0.01% | 393 |
|
2023
Q2 | $798K | Buy |
14,001
+9,460
| +208% | +$539K | ﹤0.01% | 390 |
|
2023
Q1 | $201K | Sell |
4,541
-885
| -16% | -$39.2K | ﹤0.01% | 807 |
|
2022
Q4 | $221K | Buy |
5,426
+1,754
| +48% | +$71.4K | ﹤0.01% | 707 |
|
2022
Q3 | $237K | Sell |
3,672
-3,140
| -46% | -$203K | ﹤0.01% | 832 |
|
2022
Q2 | $429K | Sell |
6,812
-16,224
| -70% | -$1.02M | ﹤0.01% | 584 |
|
2022
Q1 | $1.48M | Sell |
23,036
-16,150
| -41% | -$1.03M | ﹤0.01% | 359 |
|
2021
Q4 | $3.09M | Buy |
39,186
+5,858
| +18% | +$462K | ﹤0.01% | 252 |
|
2021
Q3 | $3.67M | Sell |
33,328
-16,474
| -33% | -$1.82M | ﹤0.01% | 245 |
|
2021
Q2 | $7.5M | Sell |
49,802
-11,949
| -19% | -$1.8M | 0.01% | 109 |
|
2021
Q1 | $7.11M | Buy |
61,751
+27,504
| +80% | +$3.17M | 0.01% | 122 |
|
2020
Q4 | $5.53M | Buy |
34,247
+18,512
| +118% | +$2.99M | 0.01% | 130 |
|
2020
Q3 | $1.34M | Sell |
15,735
-6,221
| -28% | -$529K | ﹤0.01% | 329 |
|
2020
Q2 | $1.65M | Buy |
21,956
+4,583
| +26% | +$344K | ﹤0.01% | 238 |
|
2020
Q1 | $769K | Buy |
17,373
+3,816
| +28% | +$169K | ﹤0.01% | 477 |
|
2019
Q4 | $838K | Buy |
+13,557
| New | +$838K | ﹤0.01% | 704 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 1423 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 1360 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 1368 |
|
2018
Q4 | – | Sell |
-16,571
| Closed | -$735K | – | 1441 |
|
2018
Q3 | $735K | Buy |
+16,571
| New | +$735K | ﹤0.01% | 655 |
|